News & Analysis Archives - Page 4 of 12 - Evolution Search Partners

March 2, 2017

Categories

The Antibody Quality Conundrum: Abcam Ahead of the Curve with Knockout Validation

[vc_row][vc_column][vc_column_text] In September 2016 the International Working Group for Antibody Validation (IWGAV) finally announced their five conceptual pillars, outlining recommendations to mitigate the antibody specificity and […]

February 20, 2017

Categories

Pharmaron Continue Their Global Expansion with Grand Opening of Hoddesdon Facility

[vc_row][vc_column][vc_column_text] Fully integrated contract research and manufacturing organisation Pharmaron have formally opened their Hoddesdon facility, making it the first Sino-US CRO to operate in each major […]

January 31, 2017

What Assets are J&J Actually Getting with its $30B Acquisition of Actelion?

Categories

News & Analysis

M&A Analysis: Is Johnson & Johnson’s $30B Acquisition of Actelion Overvalued?

[vc_row][vc_column][vc_column_text] Healthcare multinational Johnson & Johnson will pay $30B to acquire Swiss drugmaker Actelion in an all-cash deal. Under the conditions of the deal, Actelion will […]

January 27, 2017

Lonza Accelerates its Healthcare Continuum with $5.5B Acquisition of Capsugel

Categories

Lonza Accelerates its “Healthcare Continuum” Strategy with $5.5B Acquisition of Capsugel

[vc_row][vc_column][vc_column_text] At the end of 2016 Lonza entered into an agreement to acquire Capsugel for $5.5B in cash, including refinancing of $2B of existing Capsugel debt. […]

January 12, 2017

Categories

Drug Development IPO Analysis: Over $4.2B Raised Globally in Q4 2016 Despite Continued NASDAQ Decline

[vc_row][vc_column][vc_column_text] Whilst the depression in the value and frequency of Drug Development IPOs on the NASDAQ market continued throughout the fourth quarter of 2016, a combined […]

January 11, 2017

Illumina’s NovaSeq Platform Aims for the $100 Human Genome, but is it Good Business?

Categories

News & Analysis

Illumina’s NovaSeq Platform Targets the $100 Human Genome, but do they Risk Self-Cannibalisation?

Illumina utilised their showcase at the JP Morgan Conference to announce its new DNA sequencers, the NovaSeq 5000 and NovaSeq 6000, promising that by the end of the […]

November 29, 2016

Categories

Promising Autologous CAR-T Cell Therapies Stumble: is this the End, or Just the Beginning?

[vc_row][vc_column][vc_column_text]The field of CAR-T immunotherapy presents a tantalising idea: reengineering a patient’s immune cells to attack cancer. CAR-T immunotherapy has the potential to revolutionise the way […]

November 9, 2016

Blood of Their Blood - Timeline Infographic

Categories

Blood of Their Blood: Young Blood Transfusions & The Business of Ageing

[vc_row][vc_column][vc_column_text]The idea of transfusing blood from younger individuals to older individuals has returned to the spotlight following the commencement of clinical trials by US companies Alkahest […]

October 13, 2016

Clinical CRO & Healthcare Analytics Landscape

Categories

News & Analysis

As the Dust Settles on the Quintiles IMS Merger, which CRO will enter the Healthcare Analytics Space Next?

In May 2016 a megamerger between Quintiles, the world’s largest CRO, and healthcare data and consultancy firm IMS was announced, with the combined company branded as […]